Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
31
SYK Quote, Financials, Valuation and Earnings
Last price:
$354.95
Seasonality move
:
5.74%
Day range:
$354.37 - $355.98
52-week range:
$329.16 - $406.19
Dividend yield:
0.95%
P/E ratio:
46.58x
P/S ratio:
5.62x
P/B ratio:
6.23x
Volume:
787.3K
Avg. volume:
1.7M
1-year change:
-4.33%
Market cap:
$135.7B
Revenue:
$22.6B
EPS (TTM):
$7.62
Analysts' Opinion
-
Consensus RatingStryker Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $428.11, Stryker Corp. has an estimated upside of 20.68% from its current price of $354.74.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $316.00 representing 100% downside risk from its current price of $354.74.
Fair Value
-
According to the consensus of 22 analysts, Stryker Corp. has 20.68% upside to fair value with a price target of $428.11 per share.
SYK vs. S&P 500
-
Over the past 5 trading days, Stryker Corp. has underperformed the S&P 500 by -0.8% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Stryker Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Stryker Corp. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter Stryker Corp. reported revenues of $6.1B.
Earnings Growth
-
Stryker Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Stryker Corp. reported earnings per share of $2.22.
Enterprise value:
149.5B
EV / Invested capital:
3.84x
Price / LTM sales:
5.62x
EV / EBIT:
27.11x
EV / Revenue:
6.13x
PEG ratio (5yr expected):
1.10x
EV / Free cash flow:
36.69x
Price / Operating cash flow:
33.65x
Enterprise value / EBITDA:
22.46x
Gross Profit (TTM):
$15.1B
Return On Assets:
6.51%
Net Income Margin (TTM):
12.07%
Return On Equity:
14.06%
Return On Invested Capital:
7.89%
Operating Margin:
22.52%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $19.9B | $22B | $24.4B | $5.5B | $6.1B | |
| Gross Profit | $12B | $13.5B | $15.1B | $3.4B | $3.7B | |
| Operating Income | $4.1B | $4.7B | $5.5B | $1.2B | $1.4B | |
| EBITDA | $5.1B | $5.8B | $6.7B | $1.4B | $1.7B | |
| Diluted EPS | $6.74 | $9.33 | $7.62 | $2.16 | $2.22 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $9.5B | $9.3B | $11B | $14.7B | $13.7B | |
| Total Assets | $34.1B | $36B | $38B | $43.8B | $47.1B | |
| Current Liabilities | $4.4B | $4.6B | $7.5B | $7.7B | $7.4B | |
| Total Liabilities | $20B | $19.5B | $20.1B | $23.7B | $25.3B | |
| Total Equity | $14.2B | $16.5B | $17.9B | $20.1B | $21.8B | |
| Total Debt | $12.9B | $13.1B | $13.1B | $15.9B | $17B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $3.2B | $3.8B | $4.8B | $1.5B | $1.5B | |
| Cash From Investing | -$972M | -$2.8B | -$4.9B | -$2.2B | -$321M | |
| Cash From Financing | -$1.8B | $983M | -$588M | $2.7B | -$339M | |
| Free Cash Flow | $2.6B | $3.2B | $4.1B | $1.3B | $1.4B | |
SYK
Sector
Market Cap
$135.7B
$28M
Price % of 52-Week High
87.33%
51.03%
Dividend Yield
0.95%
0%
Shareholder Yield
0.29%
-1.54%
1-Year Price Total Return
-4.33%
-17.48%
Beta (5-Year)
0.890
0.518
Dividend yield:
0.95%
Annualized payout:
$3.24
Payout ratio:
37.81%
Growth streak:
15 years
Technicals
8-day SMA
Buy
Level
$354.25
200-day SMA
Sell
Level
$375.08
Bollinger Bands (100)
Sell
Level
359.8 - 384.24
Chaikin Money Flow
Sell
Level
-2.9M
20-day SMA
Sell
Level
$358.72
Relative Strength Index (RSI14)
Sell
Level
43.56
ADX Line
Buy
Level
35.9
Williams %R
Neutral
Level
-64.347
50-day SMA
Sell
Level
$364.49
MACD (12, 26)
Buy
Level
93.38
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
7.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.4087)
Buy
CA Score
(Annual)
Level (0.1765)
Buy
Beneish M-Score
(Annual)
Level (-2.5753)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.4636)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Stock Forecast FAQ
In the current month, SYK has received 13 Buy ratings 9 Hold ratings, and 0 Sell ratings. The SYK average analyst price target in the past 3 months is $428.11.
-
Where Will Stryker Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Stryker Corp. share price will rise to $428.11 per share over the next 12 months.
-
What Do Analysts Say About Stryker Corp.?
Analysts are divided on their view about Stryker Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Stryker Corp. is a Sell and believe this share price will drop from its current level to $316.00.
-
What Is Stryker Corp.'s Price Target?
The price target for Stryker Corp. over the next 1-year time period is forecast to be $428.11 according to 22 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is SYK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Stryker Corp. is a Buy. 13 of 22 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SYK?
You can purchase shares of Stryker Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Stryker Corp. shares.
-
What Is The Stryker Corp. Share Price Today?
Stryker Corp. was last trading at $354.95 per share. This represents the most recent stock quote for Stryker Corp.. Yesterday, Stryker Corp. closed at $354.74 per share.
-
How To Buy Stryker Corp. Stock Online?
In order to purchase Stryker Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SYK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SYK
Sector
P/E ratio
46.58x
23.89x
PEG ratio
1.10x
-0.01x
P/B ratio
6.23x
1.82x
Price / LTM sales
5.62x
1.60x
Growth Metrics
SYK
Sector
Revenue growth
10.25%
4.62%
Earnings growth
2.71%
10.88%
Revenue (5-year growth)
8.71%
6.5%
Earnings forecast
$3.13
-$0.21
Profitability
SYK
Sector
Profitability FY 2024
$14B
$3.5M
Return on invested capital
7.89%
-31.77%
Return on assets
6.51%
-27.96%
Return on equity
14.06%
-37.63%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Jan
27
Estimated Next Earnings Date
Jan
29
Balance Sheet
SYK
Sector
Total cash
$3.3B
$26.3M
Short term investments
$841M
$25.7M
Total assets
$43B
$78M
Long term debt
$17B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
